Brief: Thor Medical H1 Loss Before Tax At NOK 26.5 Mln

Thor Medical ASA

31/08/2023 06:22

Aug 31 (Reuters) - Thor Medical ASA  TRMED.OL :
    * MAIN BUSINESS FOCUS FOR THOR MEDICAL WILL BE TO REFINE
PRODUCTION TECHNOLOGY AT PILOT FACILITIES AT HERØYA
    * MAIN BUSINESS FOCUS FOR THOR MEDICAL WILL BE TO CONTINUE
DIALOG
WITH POTENTIAL CUSTOMERS IN RADIOPHARMA INDUSTRY FOR FUTURE
SUPPLY OF ALPHA EMITTERS
    * COMPANY WILL IN ADDITION EVALUATE POTENTIAL SPIN-OFF
OPTIONS FOR
CD37-PIPELINE
    * MAIN BUSINESS FOCUS FOR THOR MEDICAL WILL BE TO MATURE
CONCEPT
FOR AN INDUSTRIAL SCALE MANUFACTURING FACILITY
    * REVENUES IN FIRST HALF 2023 WAS NOK 0.8M, WITH A LOSS
BEFORE TAX
OF NOK -26.5M.

Source text for Eikon:  ID:nWkrBv0MR 
Further company coverage:  TRMED.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))